Hydroxychloroquine as Prophylaxis for COVID-19 in Healthcare Workers (HCQPreP)
Status:
Recruiting
Trial end date:
2021-06-01
Target enrollment:
Participant gender:
Summary
This a double-blind, randomized, placebo-controlled clinical trial to determine if primary
prophylaxis with hydroxychloroquine in healthcare workers reduces symptomatic COVID-19
infection. Healthcare workers will be randomized at a 1:1 allocation between intervention and
placebo arms and followed for 12 weeks. This study will enroll up to 1,700 participates in
Lafayette, Louisiana. The primary outcome will number of symptomatic COVID-19 infections.
Secondary endpoints included number of days healthcare workers are absent from work and rate
of severe infection.
Phase:
Phase 3
Details
Lead Sponsor:
Louisiana State University Health Sciences Center in New Orleans
Collaborators:
Lafayette General Health Lafayette General Medical Center University of Louisiana at Lafayette University of Louisiana Lafayette